[Blinatumomab and dasatinib reverse the positive conversion of fusion gene in Ph(+) acute lymphoblastic leukemia patient after anti-CD19 CAR-T therapy: a case report].

2022PubMedMedicine被引 1开放获取

摘要

该文献暂无收录摘要。

引用本文（GB/T 7714）

R H Mi, L Wang, L Chen, 等. [Blinatumomab and dasatinib reverse the positive conversion of fusion gene in Ph(+) acute lymphoblastic leukemia patient after anti-CD19 CAR-T therapy: a case report].[J]. PubMed, 2022.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.3760/cma.j.issn.0253-2727.2022.08.015

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。